New drug combo shows promise for Tough-to-Treat Ewing's sarcoma
Disease control
Completed
This phase II trial tested a new drug called TK216 combined with the chemotherapy drug vincristine in 15 people with Ewing's sarcoma that had come back or stopped responding to treatment. The main goal was to see how many patients' tumors shrank or disappeared. The study was comp…
Phase: PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC